Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Lilly, Incyte report trial results of baricitinib in Covid-19 patients

pharmaceutical-technologyApril 09, 2021

Tag: Lilly , Incyte , COVID-19 , Baricitinib , Remdesivir

PharmaSources Customer Service